Release Date: April 30, 2025
Expiration Date: April 30, 2026
Activity Overview
This video-based program is designed for eye care professionals to explore the diagnosis and potential treatment of patients with X-linked retinitis pigmentosa (XLRP) through a unique perspective, putting the patient’s voice front and center. A patient will lend his expertise to this program by sharing his journey living with XLRP. This online activity focuses on the clinical presentation and diagnostic evaluation of XLRP and potential opportunities for treatment in clinical trials.
Target Audience
This educational curriculum is directed toward retina specialists, ophthalmologists, low vision specialists, optometrists, pediatric ophthalmologists, genetic counselors, and other health care professionals involved in treating patients with inherited retinal diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the patient burden associated with XLRP
- Integrate strategies to facilitate diagnosis of XLRP
- Assess the safety and efficacy of gene therapies for XLRP based on clinical trial data
Lejla Vajzovic, MD, FASRS
Director, Duke Surgical Vitreoretinal Fellowship Program
Director, Duke Center for Artificial and Regenerative Vision
Co-Director, Duke Pediatric Retina and Optic Nerve Center
Director, Duke Eye Center Continuing Medical Education
Professor of Ophthalmology, Pediatrics and Biomedical Engineering with Tenure
Adult and Pediatric Vitreoretinal Surgery and Diseases
Duke University Eye Center
Durham, NC
Disclosures: Dr. Vajzovic has no financial relationships to disclose.
Ramiro Maldonado, MD
Co-Director, Pediatric Retina
Director, IRD Fellowship
Ophthalmic Genetics Center
Duke University Eye Center
Durham, NC
Disclosures: Consultant: Aldeyra Therapeutics, ProQR Therapeutics, PYC Therapeutics.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here